Depression Clinical Trial
Official title:
The Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response: A Comparison of Premenopausal, Perimenopausal and Postmenopausal Women
Verified date | January 2007 |
Source | University Health Network, Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
Objectives: This prospective investigation will compare premenopausal, perimenopausal and
postmenopausal women's response to antidepressant medication. The effects of the menstrual
cycle on the symptoms of depression and antidepressant response will also be examined.
Hypotheses: Premenopausal women will show a significantly better response to a selective
serotonin reuptake inhibitor (SSRI) than peri- or postmenopausal women. Premenopausal women
during lower estrogen phases of the menstrual cycle will complain of increased depressive
symptoms despite treatment. Perimenopausal and postmenopausal women with irregular periods
and generally low estrogen levels will show less symptom variability over time.
Method
Subjects: Eighty-four women (28 premenopausal, 28 perimenopausal, 28 postmenopausal) meeting
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for
major depressive disorder will be enrolled in the study.
Procedure: All the subjects will be followed prospectively for 12 weeks and through 2
menstrual cycles while receiving treatment with a standard SSRI antidepressant agent. All
eligible women will have a structured clinical interview and will complete questionnaires
assessing their depressive symptoms. Blood samples will be collected to evaluate for
reproductive hormone levels during the late follicular, midluteal and late luteal phases of
the menstrual cycle for two consecutive cycles. Serum SSRI levels will also be collected at
these times. As the women in the perimenopausal and postmenopausal groups either have
irregular menstrual cycles or no longer cycle, they will have blood samples drawn at
baseline and on 6 other occasions.
Research Implications: As the majority of psychiatric medication is prescribed to women,
understanding the interplay between the menstrual cycle and antidepressant medication will
ultimately translate into more diverse and improved patient care. The proposed study is one
within a developing research program, which will in part be further guided by this study.
Status | Completed |
Enrollment | 44 |
Est. completion date | October 2008 |
Est. primary completion date | October 2008 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Women, ages 18-65 years old - Fulfilling DSM-IV criteria for major depressive disorder, which is not secondary to another pre-existing psychiatric condition or to a medical condition - Hamilton Depression Rating Scale (HAM-D-17) total score of at least 16 - Able and willing to give meaningful written consent - 28 women premenopausal (having monthly periods); 28 women perimenopausal (having irregular periods); and 28 women menopausal (without a period for at least one year). - In good physical health. Exclusion Criteria: - Subjects who are taking the birth control pill currently or within the last 3 months - Subjects who plan to become pregnant or were pregnant within the last year - Subjects who are taking hormone replacement therapy (or received it within the last three [3] months) - Subjects who meet DSM-IV criteria for substance abuse (consume > 4 alcoholic beverages per day) - Subjects who have tried 2 antidepressants for this episode - Subjects who have additional diagnosed psychiatric conditions (i.e. anxiety, substance use and psychotic disorders) - Subjects who have had both ovaries surgically removed. |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | University Health Network | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
University Health Network, Toronto | Ontario Mental Health Foundation |
Canada,
Grigoriadis S, Kennedy SH, Bagby RM. A comparison of antidepressant response in younger and older women. J Clin Psychopharmacol. 2003 Aug;23(4):405-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hamilton Depression Rating Scale (HAM-D) | 12 weeks | No | |
Secondary | Clinical Global Impression (CGI) | 12 weeks | No | |
Secondary | Trimodal Anxiety Questionnaire (TAQ) | 12 weeks | No | |
Secondary | Women's Health Questionnaire | 12 weeks | No | |
Secondary | Prism calender | 12 weeks | No | |
Secondary | Biological measures (ß-estradiol, estrogen, progesterone, follicle-stimulating hormone [FSH], luteinizing hormone [LH], and testosterone) | 12 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |